tiprankstipranks
Jiutian Chemical Group Limited (SG:C8R)
SGX:C8R
Singapore Market
Want to see SG:C8R full AI Analyst Report?

Jiutian Chemical Group Limited (C8R) AI Stock Analysis

8 Followers

Top Page

SG:C8R

Jiutian Chemical Group Limited

(SGX:C8R)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
S$0.02
▲(0.00% Upside)
Action:Reiterated
Date:08/06/26
The score is primarily held down by sharply weakened financial performance (revenue decline, deep losses, negative gross profit, and negative operating/free cash flow in 2023–2025). Technical indicators are broadly neutral and do not signal a clear reversal, while valuation metrics are constrained by a negative P/E and no dividend yield data.
Positive Factors
Improving leverage and moderate debt
Leverage improving to ~0.28 indicates the company carries moderate debt relative to equity, which provides structural financial flexibility. Lower leverage reduces refinancing and interest burden risk, supporting resilience during recovery and preserving capacity for investment or working capital needs.
Negative Factors
Material revenue decline
A material multi-year revenue decline shrinks scale and undermines fixed-cost absorption, eroding competitive position. Sustained top-line contraction makes it difficult to restore margins and profitability, requiring structural changes in sales, product mix or market strategy to reestablish growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving leverage and moderate debt
Leverage improving to ~0.28 indicates the company carries moderate debt relative to equity, which provides structural financial flexibility. Lower leverage reduces refinancing and interest burden risk, supporting resilience during recovery and preserving capacity for investment or working capital needs.
Read all positive factors

Jiutian Chemical Group Limited (C8R) vs. iShares MSCI Singapore ETF (EWS)

Jiutian Chemical Group Limited Business Overview & Revenue Model

Company Description
Jiutian Chemical Group Limited, established in Singapore in 1994, operates as an investment holding company with its primary chemical manufacturing and sales activities located in the People's Republic of China. The company's product portfolio enc...
How the Company Makes Money
null...

Jiutian Chemical Group Limited Financial Statement Overview

Summary
Financial performance is weak: revenue declined materially in 2023–2025 and profitability deteriorated to deeply negative margins (including negative gross profit in the last three annual reports) with a large net loss in 2025. Cash flow also turned negative in 2023–2025, increasing funding pressure, though leverage is moderate and improved (debt-to-equity ~0.28 in 2025).
Income Statement
12
Very Negative
Balance Sheet
45
Neutral
Cash Flow
18
Very Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue393.13M108.43M243.76M598.56M2.43B2.17B
Gross Profit-147.20M-108.72M-82.26M-260.18M708.41M675.62M
EBITDA-141.98M-101.49M-118.22M-321.76M696.61M517.79M
Net Income-162.31M-239.63M-147.80M-344.64M490.50M324.90M
Balance Sheet
Total Assets1.42B626.61M1.05B1.29B1.99B1.89B
Cash, Cash Equivalents and Short-Term Investments698.48M198.16M400.41M529.62M1.11B773.55M
Total Debt234.88M127.62M289.32M265.88M134.64M228.18M
Total Liabilities469.16M248.45M427.02M523.23M764.65M1.08B
Stockholders Equity948.17M378.31M618.04M765.84M1.22B816.21M
Cash Flow
Free Cash Flow-356.18M-155.06M-171.63M-511.23M424.05M633.54M
Operating Cash Flow-328.39M-129.87M-81.58M-385.65M434.01M655.81M
Investing Cash Flow-27.72M-24.57M-89.54M-125.70M-9.85M-27.68M
Financing Cash Flow-53.04M-160.50M32.87M-732.00K-95.52M-110.89M

Jiutian Chemical Group Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.02
Negative
200DMA
0.02
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
48.11
Neutral
STOCH
38.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C8R, the sentiment is Negative. The current price of 0.02 is equal to the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 48.11 is Neutral, neither overbought nor oversold. The STOCH value of 38.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:C8R.

Jiutian Chemical Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
S$655.08M8.249.20%4.40%-8.74%-6.08%
65
Neutral
S$51.26M-4.73-10.15%0.92%-7.25%95.72%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
46
Neutral
S$11.84M-6.67-79.63%
45
Neutral
S$41.76M-0.92-48.10%-54.41%-10.14%
45
Neutral
S$11.35M-1.58-72.32%-16.32%-91.78%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:C8R
Jiutian Chemical Group Limited
0.02
>-0.01
-20.00%
SG:QES
China Sunsine Chemical Holdings Ltd.
0.68
>-0.01
-1.03%
SG:C05
Chemical Industries Far East Ltd.
0.61
0.09
18.22%
SG:M15
Matex International Limited
0.02
0.00
0.00%
SG:5DS
MegaChem Ltd.
0.45
0.05
12.50%
SG:5WV
AsiaPhos Limited
0.01
0.00
0.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 06, 2026